Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4614 per EA under NDC 67877072990. Its NADAC has been published 238 times since Feb 2, 2022.
FDA first approved this application on Jun 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
225 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877072990
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214127FDA Approved
6/10/2021
TE Code
AB
On Market Since
6/11/2021
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 238 times since Feb 2, 2022, and over the history we have for it it has declined 87.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4614 per EA |
|---|---|
| All-time high | $3.6016 (Feb 16, 2022) |
| All-time low | $0.4592 (Nov 20, 2024) |
| 52-week high | $0.6770 |
| 52-week low | $0.4614 |
| Median price | $0.7400 |
| Average price | $1.1005 |
| Largest weekly change | +54.1% (Feb 22, 2023) |
| Weeks tracked | 238 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.4614 per EA (NDC 67877072990), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 87.2%. It has been tracked across 238 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since Feb 2, 2022, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $3.6016 (Feb 16, 2022), with a median of $0.7400 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 225 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 67877072990) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.